The legal and common uses of “interchangeability” continue to be conflated.
Gillian Woollett, MA, DPhil
Advertisement
Articles by Gillian Woollett, MA, DPhil
The "interchangeable" designation has created confusion around the difference between biosimilars designated as interchangeable and those that are not.
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on Pharmacy Times
1
How Subcutaneous Isatuximab Could Compete With Daratumumab in Multiple Myeloma
2
What Does the FDA Advisory Committee’s Vote on 7 Peptides Mean for Pharmacy Practice?
3
FDA Approves SimpleScreen CRC Blood Test for Colorectal Cancer Screening
4
Beyond Off-Label: How Auvelity's Approval Changes Agitation Management in Alzheimer Disease
5